Cargando…
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy that generally conveys a poor prognosis. Currently, surgical resection is considered the lone curative treatment modality. In addition, the low prevalence of ACC has limited effective clinical trial design to develop evidence-based appr...
Autores principales: | Lebastchi, Amir H., Kunstman, John W., Carling, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483813/ https://www.ncbi.nlm.nih.gov/pubmed/23125857 http://dx.doi.org/10.1155/2012/234726 |
Ejemplares similares
-
Gene Expression and Regulation in Adrenocortical Tumorigenesis
por: Fonseca, Annabelle L., et al.
Publicado: (2012) -
Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma
por: Korah, Reju, et al.
Publicado: (2013) -
Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
por: Shariq, Omair A., et al.
Publicado: (2021) -
Role of Mitotane in Adrenocortical Carcinoma – Review and State of the art
por: Paragliola, Rosa Maria, et al.
Publicado: (2018) -
The challenge of developmental therapeutics for adrenocortical carcinoma
por: Costa, Ricardo, et al.
Publicado: (2016)